|
Vital status ascertainment in cancerlinq discovery (CLQD): Improvement in mortality capture with a supplemental data source. |
|
|
Employment - AstraZeneca; AstraZeneca |
Stock and Other Ownership Interests - AstraZeneca |
Research Funding - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca |
Other Relationship - Concerto HealthAI; Tempus |
|
|
No Relationships to Disclose |
|
|
|
|
|
Employment - AstraZeneca; Takeda |
Stock and Other Ownership Interests - AstraZeneca |
Travel, Accommodations, Expenses - AstraZeneca |
|
|
|
Stock and Other Ownership Interests - AstraZeneca |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Abbott Laboratories; Abbvie |
Consulting or Advisory Role - Deciphera; Okava Pharmaceuticals; Tactical Therapeutics; TYME |